Congress’ in-house non-partisan research arm recently produced a summary of the range of policy actions affecting 340B contract pharmacy use [...] …
Blog Posts
Bayer recently announced it will add a previously excluded drug to its list of products that face contract pharmacy restrictions. [...] …
Federal auditors recently reported no adverse findings in their first fiscal year 2024 340B audit of a pharmaceutical manufacturer. On [...] …
Key House Republicans on Tuesday introduced long-awaited—and contentious—legislation to overhaul the 340B program based on recommendations from a nonprofit group [...] …